Ladenburg Thalmann Financial Services’s Aurinia Pharmaceuticals AUPH Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$37K	Hold	1,850	–	–	﹤0.01%	3724
2019 Q3	$10K	Hold	1,850	–	–	﹤0.01%	4383
2019 Q2	$12K	Sell	1,850 -450	-20%	-$2.87K	﹤0.01%	4341
2019 Q1	$15K	Buy	2,300 +100	+5%	+$663	﹤0.01%	4165
2018 Q4	$15K	Buy	2,200 +1,500	+214%	+$8.65K	﹤0.01%	4021
2018 Q3	$5K	Hold	700	–	–	﹤0.01%	4575
2018 Q2	$4K	Hold	700	–	–	﹤0.01%	4650
2018 Q1	$4K	Hold	700	–	–	﹤0.01%	4650
2017 Q4	$3K	Hold	700	–	–	﹤0.01%	4662
2017 Q3	$4K	Sell	700 -1,500	-68%	-$9.46K	﹤0.01%	4453
2017 Q2	$13K	Sell	2,200 -700	-24%	-$4.72K	﹤0.01%	3856
2017 Q1	$21K	Buy	2,900 +1,900	+190%	+$8.78K	﹤0.01%	3518
2016 Q4	$2K	Buy	+1,000	New	+$3.22K	﹤0.01%	4507

Other funds holding AUPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AUPH Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Aurinia Pharmaceuticals (AUPH) position steady in Q4 2019 at 1,850 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #3724.

Ladenburg Thalmann Financial Services first reported a position in AUPH in Q4 2016 and has held it in 13 quarters since. 115 funds tracked by Wall St. Rank hold AUPH as of Q4 2019.

Ladenburg Thalmann Financial Services held 1,850 shares of Aurinia Pharmaceuticals worth $37K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Aurinia Pharmaceuticals share count unchanged in Q4 2019.
Aurinia Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3724 holding.
Ladenburg Thalmann Financial Services first reported a position in Aurinia Pharmaceuticals in Q4 2016 and has held it in 13 quarters since.
115 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.